-       Report 
- August 2025
-  199 Pages 
- Global 
   From       €3155EUR$3,545USD£2,777GBP 
      €3505EUR$3,939USD£3,085GBP 
          -       Report 
- April 2025
-  185 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
          -       Report 
- April 2025
-  185 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
          -       Report 
- April 2025
-  185 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
          -       Report 
- March 2025
-  180 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
           -       Report 
- February 2025
-  185 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
          -       Report 
- February 2025
-  183 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
          -       Report 
- January 2025
-  183 Pages 
- Global 
   From       €4004EUR$4,500USD£3,525GBP 
            -       Report 
- July 2025
-  150 Pages 
- Global 
   From       €2670EUR$3,000USD£2,350GBP 
      €3337EUR$3,750USD£2,937GBP 
          -       Report 
- May 2025
-  221 Pages 
- Global 
   From       €2225EUR$2,500USD£1,958GBP 
          -       Report 
- August 2025
-  143 Pages 
- Global 
   From       €2581EUR$2,900USD£2,272GBP 
            -       Report 
- October 2025
-  150 Pages 
- Global 
   From       €2536EUR$2,850USD£2,232GBP 
      €3426EUR$3,850USD£3,016GBP 
          -       Report 
- September 2025
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
          -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
          -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €2536EUR$2,850USD£2,232GBP 
      €3426EUR$3,850USD£3,016GBP 
            -       Report 
- November 2024
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
      €4316EUR$4,850USD£3,799GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- June 2025
-  150 Pages 
- Global 
   From       €2402EUR$2,699USD£2,114GBP 
       
       The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders    Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less   Read more